Вернуться к статье

МУЛЬТИОМИЧЕСКИЙ ИИ ДЛЯ ПЕРСОНАЛИЗИРОВАННОЙ ИНТЕНСИВНОЙ ТЕРАПИИ: ОБЗОР ЦИФРОВЫХ ДВОЙНИКОВ, CRISPR И ОБЪЯСНИМЫХ СИСТЕМ

Multi-Omics Data Comparison

Omics Layer

Biological Insight

Clinical Relevance

Challenges

Genomics

DNA mutations

Disease risk prediction

Static, expensive

Transcriptomics

Gene expression

Disease activity

Temporal variability

Proteomics

Protein signaling

Functional pathways

Complex measurement

Metabolomics

Biochemical state

Real-time physiology

High variability

Epigenomics

Gene regulation

Environmental effects

Data complexity

Microbiomics

Host-microbe interaction

Immunity & gut health

Standardization issues